Sawtooth Asset Management »

Terns Pharmaceuticals shares owned by Sawtooth Asset Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Sawtooth Asset Management from 13F filings

Historical chart of Sawtooth Asset Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Sawtooth Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Sawtooth Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $68k 11k 6.49

More positions owned by Sawtooth Asset Management

Mirati Therapeutics
Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
Sprott Physical Gold & Silve Tr Unit (CEF)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)

View all positions for Sawtooth Asset Management

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Vivo Capital
VR Adviser
BlackRock
Braidwell
Franklin Resources
Vanguard Group
Fairmount Funds Management
Millennium Management
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Perceptive Advisors
Decheng Capital
Russell Investments
Norges Bank Investment Management

View all funds holding Terns Pharmaceuticals